Nelson B Watts

Summary

Affiliation: University of Cincinnati
Country: USA

Publications

  1. ncbi Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk
    Nelson B Watts
    University of Cincinnati Osteoporosis Center, Cincinnati, OH, USA
    J Clin Densitom 7:255-61. 2004
  2. ncbi Is it ethical to use placebos in osteoporosis clinical trials?
    Nelson B Watts
    Bone Health and Osteoporosis Center, University of Cincinnati College of Medicine, 222 Piedmont Avenue, Suite 4300, Cincinnati, OH 45219, USA
    Curr Osteoporos Rep 2:31-6. 2004
  3. doi Risedronate on 2 consecutive days a month reduced vertebral fracture risk at 1year compared with historical placebo
    Nelson B Watts
    Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA
    J Clin Densitom 13:56-62. 2010
  4. doi Bisphosphonates in the treatment of osteoporosis
    Dima L Diab
    Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Cincinnati VA Medical Center, University of Cincinnati, 3125 Eden Avenue, PO Box 670547, Cincinnati, OH 45267, USA
    Endocrinol Metab Clin North Am 41:487-506. 2012
  5. doi Diagnosis and treatment of osteoporosis in older adults
    Dima L Diab
    Division of Endocrinology Metabolism, Department of Internal Medicine, Cincinnati VA Medical Center, University of Cincinnati Bone Health and Osteoporosis Center, Cincinnati, OH 45219, USA
    Endocrinol Metab Clin North Am 42:305-17. 2013
  6. ncbi Secondary osteoporosis: differential diagnosis and workup
    Dima L Diab
    Department of Internal Medicine, Division of Endocrinology Metabolism, Cincinnati VA Medical Center, University of Cincinnati Bone Health and Osteoporosis Center Mercy Health Osteoporosis and Bone Health Services, Cincinnati, Ohio
    Clin Obstet Gynecol 56:686-93. 2013
  7. doi 2013 International Society for Clinical Densitometry Position Development Conference: Task Force on Normative Databases
    Nelson B Watts
    Mercy Health Osteoporosis and Bone Health Services, Cincinnati, OH, USA Electronic address
    J Clin Densitom 16:472-81. 2013
  8. doi Risk factors for the development of osteoporosis and osteoporotic fractures among older men
    Maria Thomas-John
    Division of Immunology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267 0563, USA
    J Rheumatol 36:1947-52. 2009
  9. doi Long-term use of bisphosphonates in osteoporosis
    Nelson B Watts
    University of Cincinnati Bone Health and Osteoporosis Center, Cincinnati, Ohio 45219, USA
    J Clin Endocrinol Metab 95:1555-65. 2010
  10. pmc Dynamic bone quality: a noninvasive measure of bone's biomechanical property in osteoporosis
    Amit Bhattacharya
    Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    J Clin Densitom 13:228-36. 2010

Collaborators

Detail Information

Publications28

  1. ncbi Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk
    Nelson B Watts
    University of Cincinnati Osteoporosis Center, Cincinnati, OH, USA
    J Clin Densitom 7:255-61. 2004
    ..Although patients showing an increase in BMD had a lower fracture risk than patients showing a decrease in BMD, greater increases in BMD did not necessarily predict greater decreases in fracture risk...
  2. ncbi Is it ethical to use placebos in osteoporosis clinical trials?
    Nelson B Watts
    Bone Health and Osteoporosis Center, University of Cincinnati College of Medicine, 222 Piedmont Avenue, Suite 4300, Cincinnati, OH 45219, USA
    Curr Osteoporos Rep 2:31-6. 2004
    ....
  3. doi Risedronate on 2 consecutive days a month reduced vertebral fracture risk at 1year compared with historical placebo
    Nelson B Watts
    Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA
    J Clin Densitom 13:56-62. 2010
    ..The use of appropriate historical control data may provide an alternative design to assess fracture effects in osteoporosis trials for which simultaneous placebo-controlled data are unavailable...
  4. doi Bisphosphonates in the treatment of osteoporosis
    Dima L Diab
    Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Cincinnati VA Medical Center, University of Cincinnati, 3125 Eden Avenue, PO Box 670547, Cincinnati, OH 45267, USA
    Endocrinol Metab Clin North Am 41:487-506. 2012
    ..For most patients with osteoporosis, the benefits of treatment outweigh the risks...
  5. doi Diagnosis and treatment of osteoporosis in older adults
    Dima L Diab
    Division of Endocrinology Metabolism, Department of Internal Medicine, Cincinnati VA Medical Center, University of Cincinnati Bone Health and Osteoporosis Center, Cincinnati, OH 45219, USA
    Endocrinol Metab Clin North Am 42:305-17. 2013
    ..Bone-active agents should be prescribed for older patients with osteoporosis to decrease fracture risk. Nonskeletal risk factors for fracture and psychosocial impairment must be identified and managed, and therapy must be individualized...
  6. ncbi Secondary osteoporosis: differential diagnosis and workup
    Dima L Diab
    Department of Internal Medicine, Division of Endocrinology Metabolism, Cincinnati VA Medical Center, University of Cincinnati Bone Health and Osteoporosis Center Mercy Health Osteoporosis and Bone Health Services, Cincinnati, Ohio
    Clin Obstet Gynecol 56:686-93. 2013
    ..Further testing may be performed in selected patients depending on the clinical picture and results of the initial workup. ..
  7. doi 2013 International Society for Clinical Densitometry Position Development Conference: Task Force on Normative Databases
    Nelson B Watts
    Mercy Health Osteoporosis and Bone Health Services, Cincinnati, OH, USA Electronic address
    J Clin Densitom 16:472-81. 2013
    ..4. A uniform Caucasian (non-race adjusted) female reference database should be used to calculate T-scores for men of all ethnic groups. ..
  8. doi Risk factors for the development of osteoporosis and osteoporotic fractures among older men
    Maria Thomas-John
    Division of Immunology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267 0563, USA
    J Rheumatol 36:1947-52. 2009
    ....
  9. doi Long-term use of bisphosphonates in osteoporosis
    Nelson B Watts
    University of Cincinnati Bone Health and Osteoporosis Center, Cincinnati, Ohio 45219, USA
    J Clin Endocrinol Metab 95:1555-65. 2010
    ..Uncommon side effects have emerged in postapproval use. Because bisphosphonates accumulate in bone and are released for months or years after treatment is stopped, it is reasonable to consider the clinical question of how long to treat...
  10. pmc Dynamic bone quality: a noninvasive measure of bone's biomechanical property in osteoporosis
    Amit Bhattacharya
    Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    J Clin Densitom 13:228-36. 2010
    ....
  11. doi Vertebral fracture risk is reduced in women who lose femoral neck BMD with teriparatide treatment
    Nelson B Watts
    University of Cincinnati, Cincinnati, Ohio 45219 4231, USA
    J Bone Miner Res 24:1125-31. 2009
    ..In conclusion, loss of FN BMD at 12 mo in postmenopausal women with osteoporosis treated with TPTD is nevertheless consistent with a good treatment response in terms of VF risk reduction...
  12. ncbi Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA)
    Nelson B Watts
    University of Cincinnati Bone Health and Osteoporosis Center, 222 Piedmont Avenue, Suite 4300, Cincinnati, OH 45219, USA
    Osteoporos Int 15:847-54. 2004
    ..This paper reviews the fundamentals of positioning, scan analysis, and interpretation for central DXA and highlights some of the common pitfalls that may lead to erroneous results...
  13. ncbi Risedronate prevents new vertebral fractures in postmenopausal women at high risk
    Nelson B Watts
    University of Cincinnati, Cincinnati, Ohio 45219, USA
    J Clin Endocrinol Metab 88:542-9. 2003
    ..Significant reduction in fracture risk after 1 yr is an important benefit in patients at high risk for fracture because, without treatment, these patients are likely to sustain new fractures in the near term...
  14. ncbi Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate
    Nelson B Watts
    University of Cincinnati, Cincinnati, Ohio 45219, USA
    Osteoporos Int 14:437-41. 2003
    ..The use of appropriate historical control data provides an approach to the assessment of fracture effects in osteoporosis trials for which placebo-controlled data are not available...
  15. doi The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice
    Nelson B Watts
    University of Cincinnati Bone Health and Osteoporosis Center, Cincinnati, OH 45219, USA
    J Womens Health (Larchmt) 20:525-31. 2011
    ..Acceptance and clinical use of FRAX may help identify men and women at increased risk for osteoporotic fracture, but implementing the tool into clinical practice may be a challenge for busy physicians...
  16. ncbi Comparison of risedronate to alendronate and calcitonin for early reduction of nonvertebral fracture risk: results from a managed care administrative claims database
    Nelson B Watts
    University of Cincinnati Bone Health and Osteoporosis Center, 222 Piedmont Ave, Suite 4300, Cincinnati, OH, 45219, USA
    J Manag Care Pharm 10:142-51. 2004
    ....
  17. ncbi Is it ethical to use placebos in osteoporosis clinical trials?
    Nelson B Watts
    Bone Health and Osteoporosis Center, University of Cincinnati College of Medicine, 222 Piedmont Avenue, Suite 4300, Cincinnati, OH 45219, USA
    Curr Rheumatol Rep 6:79-84. 2004
    ....
  18. ncbi Bisphosphonate treatment of osteoporosis
    Nelson B Watts
    University of Cincinnati College of Medicine, University of Cincinnati Bone Health and Osteoporosis Center, Cincinnati, OH, USA
    Clin Geriatr Med 19:395-414. 2003
    ....
  19. ncbi Diagnosis and evaluation of patients with osteoporosis
    Nelson B Watts
    University of Cincinnati College of Medicine, Bone Health and Osteoporosis Center, 222 Piedmont Avenue, Suite 4300, Cincinnati, OH 45219, USA
    South Med J 97:540-1. 2004
  20. doi Use of drug holidays in women taking bisphosphonates
    Dima L Diab
    From the 1Cincinnati VA Medical Center, Cincinnati, OH, and 2Mercy Health Osteoporosis and Bone Health Services, Cincinnati, OH
    Menopause 21:195-7. 2014
    ..The duration of therapy and the length of the holiday should be based on clinical judgment. ..
  21. doi Postmenopausal osteoporosis
    Dima L Diab
    aDepartment of Internal Medicine, Division of Endocrinology Metabolism bMercy Health Osteoporosis and Bone Health Services, Cincinnati, Ohio, USA
    Curr Opin Endocrinol Diabetes Obes 20:501-9. 2013
    ..The aim of this study is to provide a thorough updated review of the diagnosis and treatment of postmenopausal osteoporosis...
  22. doi Denosumab in osteoporosis
    Dima L Diab
    University of Cincinnati Bone Health and Osteoporosis Center, Cincinnati VA Medical Center, Division of Endocrinology Metabolism, Department of Internal Medicine, 260 Stetson St, Suite 4200, Cincinnati, OH 45219, USA 1 513 558 4444 1 513 558 8581
    Expert Opin Drug Saf 13:247-53. 2014
    ..Denosumab is a fully human monoclonal antibody against the receptor activator of nuclear factor kappa-B ligand. It is an antiresorptive agent that reduces osteoclastogenesis...
  23. pmc A label-free electronic biosensor for detection of bone turnover markers
    Yeo Heung Yun
    Nanoworld and Smart Materials and Devices Laboratory, College of Engineering, University of Cincinnati, Cincinnati, OH 45221, USA E mail
    Sensors (Basel) 9:7957-69. 2009
    ..It is hoped that analysis of bone turnover markers can indicate the beginning of bone diseases such as osteoarthritis and osteoporosis so that treatment might start early when it is most effective...
  24. ncbi Intraoperative PTH: effect of sample timing and vitamin D status
    Melissa McCarty Statham
    Department of Otolaryngology Head and Neck Surgery, University of Cincinnati School of Medicine, Cincinnati, OH, USA
    Otolaryngol Head Neck Surg 136:946-51. 2007
    ..To assess the effect of timing of intraoperative parathormone (iPTH) samples and 25-hydroxyvitamin D (25-OHD) status on decision-making during parathyroidectomy...
  25. ncbi Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease
    Darcey L H Smith
    Division of Digestive Diseases, University of Cincinnati, Cincinnati, OH 45267 0595, USA
    J Clin Densitom 9:105-13. 2006
    ....
  26. ncbi Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results
    Nelson B Watts
    Department of Medicine, University of Cincinnati College of Medicine, OH, USA
    J Reprod Med 47:82-92. 2002
    ..Other strategies include nonpharmacologic interventions, such as calcium supplements, vitamin D and exercise...
  27. doi Osteonecrosis of the jaw
    Nelson B Watts
    Department of Internal Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    South Med J 101:160-5. 2008
    ..v. bisphosphonate therapy for cancer. Patients with osteoporosis receiving lower-dose bisphosphonate therapy do not require special precautions, but should be informed of the low risk of this complication...
  28. ncbi Comparison of serum calcium change following thyroid and nonthyroid neck surgery
    Nicholas Mehta
    Dept of Otolaryngology Head and Neck Surgery, Cincinnati, Ohio 45267 0001, USA
    Otolaryngol Head Neck Surg 134:901-6. 2006
    ..Compare serum calcium changes following thyroid and nonthyroid/parathyroid neck surgery...